Literature DB >> 15262270

3-Hydroxyglutaric acid fails to affect the viability of primary neuronal rat cells.

F Freudenberg1, Z Lukacs, K Ullrich.   

Abstract

Glutaric aciduria type I (GA I) is an autosomal recessive inherited metabolic disorder caused by deficiency of glutaryl-CoA dehydrogenase (GCD) resulting in the accumulation of 3-hydroxyglutaric acid (3OHG), glutaric acid and glutaconic acid in body fluids. GA I is characterized by a specific age- and brain region-dependent neuropathology. Previous studies using organotypic slice cultures of rats and primary chick embryo telencephalon cell cultures indicated that death of neurons is a consequence of an excitotoxic mechanism induced by 3OHG. We used primary neuronal cells of neonatal rats as a model system to test cell viability after treatment with 3OHG. Western blot analysis was used to prove the expression of functional N-methyl-D-aspartate (NMDA) receptors revealing no alteration in the expression of NMDA-2a and -2b receptor subtypes in response to 3OHG. When neuronal cells cultured for 10 or 20 days were treated with 1 mM glutamate, the viability of cells was reduced by 40%. This effect could be prevented by coincubation with the NMDA receptor antagonist MK801. In contrast, incubation of cells with 3OHG for up to 24 h in concentrations of 4-8 mM did not cause increased cell death as compared with untreated control cultures. These results indicate that 3OHG is not excitotoxic in this model of neuronal rat cell cultures despite the presence of functional NMDA receptors. Therefore, alternative or additional pathomechanisms than excitotoxicity may be relevant for neurodegeneration in GA I.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15262270     DOI: 10.1016/j.nbd.2004.05.001

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  7 in total

1.  Energy metabolism is compromised in skeletal muscle of rats chronically-treated with glutaric acid.

Authors:  Gustavo da C Ferreira; Patrícia F Schuck; Carolina M Viegas; Anelise Tonin; Alexandra Latini; Carlos S Dutra-Filho; Angela T S Wyse; Clóvis M D Wannmacher; Carmen R Vargas; Moacir Wajner
Journal:  Metab Brain Dis       Date:  2007-01-13       Impact factor: 3.584

2.  Glutaric aciduria type 1 metabolites impair the succinate transport from astrocytic to neuronal cells.

Authors:  Jessica Lamp; Britta Keyser; David M Koeller; Kurt Ullrich; Thomas Braulke; Chris Mühlhausen
Journal:  J Biol Chem       Date:  2011-03-29       Impact factor: 5.157

3.  Biochemistry and bioenergetics of glutaryl-CoA dehydrogenase deficiency.

Authors:  S W Sauer
Journal:  J Inherit Metab Dis       Date:  2007-09-21       Impact factor: 4.982

4.  White matter injury induced by perinatal exposure to glutaric acid.

Authors:  Silvia Olivera-Bravo; Eugenia Isasi; Anabel Fernández; Juan Carlos Rosillo; Marcie Jiménez; Gabriela Casanova; María Noel Sarlabós; Luis Barbeito
Journal:  Neurotox Res       Date:  2013-12-03       Impact factor: 3.911

5.  Age and brain structural related effects of glutaric and 3-hydroxyglutaric acids on glutamate binding to plasma membranes during rat brain development.

Authors:  Karina B Dalcin; Rafael B Rosa; Anna L Schmidt; Juliana S Winter; Guilhian Leipnitz; Carlos S Dutra-Filho; Clóvis M D Wannmacher; Lisiane O Porciúncula; Diogo O Souza; Moacir Wajner
Journal:  Cell Mol Neurobiol       Date:  2007-09-05       Impact factor: 5.046

6.  New insights into the causes of human illness due to consumption of azaspiracid contaminated shellfish.

Authors:  O P Chevallier; S F Graham; E Alonso; C Duffy; J Silke; K Campbell; L M Botana; C T Elliott
Journal:  Sci Rep       Date:  2015-04-30       Impact factor: 4.379

7.  Increased glutamate receptor and transporter expression in the cerebral cortex and striatum of gcdh-/- mice: possible implications for the neuropathology of glutaric acidemia type I.

Authors:  Valeska Lizzi Lagranha; Ursula Matte; Talita Giacomet de Carvalho; Bianca Seminotti; Carolina Coffi Pereira; David M Koeller; Michael Woontner; Stephen I Goodman; Diogo Onofre Gomes de Souza; Moacir Wajner
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.